Oncotelic Therapeutics, Inc. (OTLC) — Total Liabilities
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $131.36M | +584.2% |
| 2024 | $19.20M | +4.3% |
| 2023 | $18.40M | +8.7% |
| 2022 | $16.92M | — |
| 2011 | $2.26M | -79.1% |
| 2010 | $10.82M | — |
| Fiscal Year | Total Liabilities | Change YoY |
|---|---|---|
| 2025 | $131.36M | +584.2% |
| 2024 | $19.20M | +4.3% |
| 2023 | $18.40M | +8.7% |
| 2022 | $16.92M | — |
| 2011 | $2.26M | -79.1% |
| 2010 | $10.82M | — |